Allergan Announces Conversion Rate On Outstanding LYONs.Business Editors & Health/Medical Writers IRVINE, Calif.--(BUSINESS WIRE)--July 26, 2002 Allergan, Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) today announced that as a result of the distribution of Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. , Inc. common stock on June 29, 2002, the conversion rate for Allergan's outstanding Liquid Yield Option Notes Liquid yield option note (LYON) Zero-coupon, callable, putable, convertible bond developed by Merrill Lynch & Co. ("LYONs") due 2020 has been adjusted. Pursuant to the formula provided in the LYONs Indenture, the conversion rate has changed from 5.7615 shares of Allergan's common stock per $1,000 face amount of the notes to 6.0273 shares of Allergan's common stock per $1,000 face amount of the note. About Allergan, Inc. Allergan, Inc., with headquarters in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). , is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion